[1]
|
Francois, G., Hallauer, J. and Van Damme, P. (2002) Hepatitis B vaccination: How to reach risk groups. Vaccine, 21, 1-4.
|
[2]
|
Rantala, M. and van de Laar, M.J. (2008) Surveillance and epidemiology of hepatitis B and C in Europe—A review. Euro Surveill, 13.
|
[3]
|
Szmuness, W., Stevens, C.E., Harley, E.J., Zang, E.A., Oleszko, W.R., William, D.C., Sadovsky, R., Morrison, J.M. and Kellner, A. (1980) Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in. The New England Journal of Medicine, 303, 833-841. http://dx.doi.org/10.1056/NEJM198010093031501
|
[4]
|
Valenzuela, P., Medina, A. and Rutter, W. (1982) Synthesis and assembly of Hepatitis-B virus surface-antigen particles in yeast. Nature, 298, 347-350. http://dx.doi.org/10.1038/298347a0
|
[5]
|
Qin, S., Tang, H., Zhao, L., He, F., Lin, Y., Liu, L. and He, X. (2003) Cloning of HBsAg-encoded genes in different vectors and their expression in eukaryotic cells. World Journal of Gastroenterology, 9, 1111-1113.
|
[6]
|
Tan, G., Yusoff, K., Seow, H. and Tan, W. (2005) Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7. Journal of Medical Virology, 77, 475-480. http://dx.doi.org/10.1002/jmv.20479
|
[7]
|
Smith, G. (1985) Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science, 228, 1315-1317. http://dx.doi.org/10.1126/science.4001944
|
[8]
|
Smith, G. and Petrenko, V. (1997) Phage display. Chemical Reviews, 97, 391-410. http://dx.doi.org/10.1021/cr960065d
|
[9]
|
Vidova, B., Godany, A. and Sturdik, E. (2008) Phage display—A tool for detection and Prevention against pathogens. Nova Biotechnologica, 8, 23-33.
|
[10]
|
Erdag, B., Balcioglu, K., Kumbasar, A., Celikbicak, O., Zeder-Lutz, G., Altschuh, D., Salih, B. and Baysal, K. (2007) Novel short peptides isolated from phage display library inhibit vascular endothelial growth factor activity. Molecular Biotechnology, 35, 51-63. http://dx.doi.org/10.1385/MB:35:1:51
|
[11]
|
Prachasuphap, A., University, K., Kittigul, C., University, K., Sunthoranandh, P., University, K., Dhepakson, P., Center, M.B., Buddhirakkul, N., Center, M.B., Balachandra, K. and Medical Biotechnology Center, M.o.P.H. (2006) Construction of recombinant monoclonal antibody against hepatitis b surface antigen by phage display. Animal Cell Technology: Basic & Applied Aspects, 14, 227-232. http://dx.doi.org/10.1007/1-4020-4457-7_31
|
[12]
|
Erdag, B., Balcioglu, B., Bahadir, A., Serhatli, M., Kacar, O., Bahar, A., Seker, U., Akgun, E., Ozkan, A., Kilic, T., Tamerler, C. and Baysal, K. (2011) Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2. Biotechnology and Applied Biochemistry, 58, 412-422. http://dx.doi.org/10.1002/bab.61
|
[13]
|
Tamerler, C., Khatayevich, D., Gungormus, M., Kacar, T., Oren, E.E., Hnilova, M. and Sarikaya, M. (2010) Molecular biomimetics: GEPI-based biological routes to technology. Biopolymers, 94, 78-94. http://dx.doi.org/10.1002/bip.21368
|
[14]
|
Bayrovic, K., Erdag, B., Atalay, O.E. and Cirakoglu, B. (2001) Full resistance to tobacco mosaic virus infection conferred by the transgenic expression of a recombinant antibody in tobacco. Biotechnology & Biotechnology Equipment, 15, 21-27.
|
[15]
|
Tang, K., Yusoff, K. and Tan, W. (2009) Display of Hepatitis B Virus PreS1 peptide on bacteriophage T7 and its potential in gene delivery into HepG2 cells. Journal of Virological Methods, 159, 194-199. http://dx.doi.org/10.1016/j.jviromet.2009.03.015
|
[16]
|
Solomon, B. (2005) Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer’s disease vaccination. Vaccine, 23, 2327-2330. http://dx.doi.org/10.1016/j.vaccine.2005.01.034
|
[17]
|
Fang, J., Wang, G., Yang, Q., Song, J., Wang, Y. and Wang, L. (2005) The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model. Vaccine, 23, 4860-4866. http://dx.doi.org/10.1016/j.vaccine.2005.05.024
|
[18]
|
Kubar, A., Yapar, M., Ozyurt, M., Haznedaroglu, T. and Gun, H. (1988) Cloning of hepatitis B virus surface gene region to Escherichia coli. Flora, 6, 108-113.
|
[19]
|
Sambrook, J., Fritsch, E.E. and Maniatis, T. (1989) Molecular cloning: A laboratory manual. Cold Spring Harbor Lab. Press, New York.
|
[20]
|
Sorensen, H. and Mortensen, K. (2005) Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microbial Cell Factories, 4. http://dx.doi.org/10.1016/j.vaccine.2005.05.024
|
[21]
|
Lunin, V.G., Gol’dberg, E.Z., Grigor’ev, V.G., Mikhailov, M.M., Khudiakov, I.E., Skripkin, E.A., Smirnov, V.D., Naroditsky, B.S., Ketiladze, E.S. and Tikhonenko, T.I. (1983) Cloning and ex-pression of gene coding the hepatitis B virus surface antigen (HBsag) in Escherichia coli. Doklady Akademii Nauk Sssr, 268, 496-498.
|
[22]
|
Guan, Z., Guo, B., Huo, Y., Guan, Z. and Wei, Y. (2010) Overview of expression of hepatitis B surface antigen in transgenic plants. Vaccine, 28, 7351-7362. http://dx.doi.org/10.1016/j.vaccine.2010.08.100
|
[23]
|
Vianna, C.O., da Silva e Mouta Junior, S., de Oliveira da Silva, G., da Silva Freire, M. and de Moraes, M.T. (2003) Screening of CHO cell clones expressing histidine-tagged major S hepatitis B surface protein using a semi-quantitative PCR protocol. Journal of Virological Methods, 114, 171-174. http://dx.doi.org/10.1016/j.jviromet.2003.08.007
|
[24]
|
Barbas, C.F.I., Burton, D.R., Scott, J.K. and Silverman, G.J. (2001) Phage display: A laboratory manual. Cold Spring Harbor Lab. Press, New York.
|
[25]
|
Rakonjac, J., Bennett, N., Spagnuolo, J., Gagic, D. and Russel, M. (2011) Filamentous bacteriophage: Biology, phage display and nanotechnology applications. Current Issues in Molecular Biology, 13, 51-75.
|
[26]
|
Irving, M.B., Pan, O. and Scott, J.K. (2001) Randompeptide libraries and antigen fragment libraries for epitope mapping and the development of vaccines and diagnostics. Current Opinion in Chemical Biology, 5, 314-324. http://dx.doi.org/10.1016/S1367-5931(00)00208-8
|
[27]
|
Willis, A., Perham, R. and Wraith, D. (1993) Immunological properties of foreign peptides in multiple display on a filamentous bacteriophage. Gene, 128, 79-83. http://dx.doi.org/10.1016/0378-1119(93)90156-W
|
[28]
|
Molenaar, T., Michon, I., de Haas, S., van Berkel, T., Kuiper, J. and Biessen, E. (2002) Uptake and processing of modified bacteriophage M13 in mice: Implications for phage display. Virology, 293, 182-191. http://dx.doi.org/10.1006/viro.2001.1254
|
[29]
|
Wang, L. and Yu, M. (2004) Epitope identification and discovery using phage display libraries: Applications in vaccine development and diagnostics. Current Drug Targets, 5, 1-15. http://dx.doi.org/10.2174/1389450043490668
|
[30]
|
Scala, G., Chen, X., Liu, W., Telles, J.N., Cohen, O.J., Vaccarezza, M., Igarashi, T. and Fauci, A.S. (1999) Selection of HIV-specific immunogenic epitopes by screening random peptide. Journal of Immunology, 162, 6155-6161.
|
[31]
|
Puntoriero, G., Meola, A., Lahm, A., Zucchelli, S., Ercole, B.B., Tafi, R., Pezzanera, M., Mondelli, M.U., Cortese, R., Tramontano, A., Galfre, G. and Nicosia, A. (1998) Towards a solution for hepatitis C virus hypervariability: mimotopes of the. The EMBO Journal, 17, 3521-3533. http://dx.doi.org/10.1093/emboj/17.13.3521
|
[32]
|
Frenkel, D., Katz, O. and Solomon, B. (2000) Immunization against Alzheimer’s beta-amyloid plaques via EFRH phage. Proceedings of the National Academy of Sciences of the United Stated of America, 97, 11455-11459. http://dx.doi.org/10.1073/pnas.97.21.11455
|
[33]
|
Manoutcharian, K., Diaz-Orea, A., Gevorkian, G., Fragoso, G., Acero, G., Gonzalez, E., de Aluja, A., Villalobos, N., Gomez-Conde, E. and Sciutto, E. (2004) Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis. Veterinary Immunology and Immunopathology, 99, 11-24. http://dx.doi.org/10.1016/j.vetimm.2003.12.009
|
[34]
|
Solomon, B. (2007) Active immunization against Alzheimer’s beta-amyloid peptide using phage display technology. Vaccine, 25, 3053-3056. http://dx.doi.org/10.1016/j.vaccine.2007.01.069
|
[35]
|
Morales, J., Martinez, J., Manoutcharian, K., Hernandez, M., Fleury, A., Gevorkian, G., Acero, G., Blancas, A., Toledo, A., Cervantes, J., Maza, V., Quet, F., Bonnabau, H., de Aluja, A., Fragoso, G., Larralde, C. and Sciutto, E. (2008) Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis. Vaccine, 26, 2899-2905. http://dx.doi.org/10.1016/j.vaccine.2008.03.042
|
[36]
|
Greenwood, J., Willis, A.E. and Perham, R.N. (1991) Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens. Journal of Molecular Biology, 220, 821-827. http://dx.doi.org/10.1016/0022-2836(91)90354-9
|
[37]
|
Mirano-Bascos, D., Tary-Lehmann, M. and Landry, S. (2008) Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120. European Journal of Immunology, 38, 1231-1237. http://dx.doi.org/10.1002/eji.200738011
|
[38]
|
Chiang, C., Benencia, F. and Coukos, G. (2010) Whole tumor antigen vaccines. Seminars in Immunology, 22, 132-143. http://dx.doi.org/10.1016/j.smim.2010.02.004
|
[39]
|
Kolodziej, P. and Young, R. (1991) Epitope tagging and protein surveillance. Methods in Enzymology, 194, 508-519. http://dx.doi.org/10.1016/0076-6879(91)94038-E
|
[40]
|
Ozdemir-Bahadir, A., Balcioglu, B., Uzyol, K., Hatipoglu, I., Sogut, I., Basalp, A. and Erdag, B. (2011) Phage Displayed HBV Core Antigen with Immunogenic Activity. Applied Biochemistry and Biotechnology, 165, 1437-1447. http://dx.doi.org/10.1007/s12010-011-9365-1
|